Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world.
Arai T, Lefèvre T, Hovasse T, Morice MC, Garot P, Benamer H, Unterseeh T, Hayashida K, Watanabe Y, Bouvier E, Cormier B, Chevalier B. Arai T, et al. Among authors: chevalier b. J Cardiol. 2017 Mar;69(3):565-569. doi: 10.1016/j.jjcc.2016.04.012. Epub 2016 Jun 7. J Cardiol. 2017. PMID: 27288330 Free article.
First-in-human feasibility and safety study of a true bifurcated stent for the treatment of bifurcation coronary artery lesions (DBS stent): six month angiographic results and five year clinical follow-up.
Dibie A, Chevalier B, Guyon P, Fajadet J, Lefèvre T, Slama MS, Royer T, Glatt B, Philippe F, Laborde F, Larrazet F. Dibie A, et al. Among authors: chevalier b. EuroIntervention. 2008 Mar;3(5):558-65. doi: 10.4244/eijv3i5a101. EuroIntervention. 2008. PMID: 19608481
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
Chevalier B, Silber S, Park SJ, Garcia E, Schuler G, Suryapranata H, Koolen J, Hauptmann KE, Wijns W, Morice MC, Carrie D, van Es GA, Nagai H, Detiege D, Paunovic D, Serruys PW; NOBORI 1 Clinical Investigators. Chevalier B, et al. Circ Cardiovasc Interv. 2009 Jun;2(3):188-95. doi: 10.1161/CIRCINTERVENTIONS.108.823443. Epub 2009 May 8. Circ Cardiovasc Interv. 2009. PMID: 20031715 Clinical Trial.
[Percutaneous aortic valve implantation: results and perspectives].
Hovasse T, Lefèvre T, Morice MC, Chevalier B, Hayashida K, Garot P, Romano M, Donzeau-Gouge P, Farge A, Bouvier E, Cormier B. Hovasse T, et al. Among authors: chevalier b. Presse Med. 2011 Jul-Aug;40(7-8):732-9. doi: 10.1016/j.lpm.2011.02.037. Epub 2011 Apr 20. Presse Med. 2011. PMID: 21511426 French.
Transfemoral aortic valve implantation new criteria to predict vascular complications.
Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. Hayashida K, et al. Among authors: chevalier b. JACC Cardiovasc Interv. 2011 Aug;4(8):851-8. doi: 10.1016/j.jcin.2011.03.019. JACC Cardiovasc Interv. 2011. PMID: 21851897 Free article.
Is there a need for dedicated bifurcation devices?
Lefèvre T, Chevalier B, Louvard Y. Lefèvre T, et al. Among authors: chevalier b. EuroIntervention. 2010 Dec;6 Suppl J:J123-9. doi: 10.4244/EIJV6SUPJA20. EuroIntervention. 2010. PMID: 21930476 Review. No abstract available.
475 results